Acceptance decreased by 85 percent among those receiving the Pfizer vaccine and 94 percent among those receiving AstraZenecase, one month after the first dose. Shows a study from Public Health Scotland, reports BBC.
Among patients 80 years of age or older, admission decreased by 81 percent, when the two vaccines were added together, according to the study.
These are the first signs of a vaccine impacting healthcare in the UK. No numbers reported from England.
Research leader Aziz Sheikh at the University of Edinburgh described the results as “extremely impressive,” and says the vaccine works amazingly well.
These results are very encouraging and give us ample reason to be optimistic about the future.
In the Pfizer studies, a second dose of the vaccine was administered three weeks later. However, the UK chose to delay the second dose of both vaccines for three months.
The preliminary results presented now include 1.14 million vaccines administered between December 8 and February 15. The study is part of the EAVE II project, which is tracking the epidemic and vaccination in one form or another in real time. There, admissions were compared between those who received the vaccine and those who did not.
The study does not include patients who died in private accommodations. It also did not examine the risk of infection but only the risk of serious illness.